Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats*
- 1 February 2004
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 32 (2) , 539-545
- https://doi.org/10.1097/01.ccm.0000109774.99665.22
Abstract
Hemoglobin-vesicle (HbV) has been developed to provide oxygen-carrying ability to plasma expanders. Its ability to restore the systemic condition after hemorrhagic shock was evaluated in anesthetized Wistar rats for 6 hrs after resuscitation. The HbV was suspended in 5 g/dL recombinant human serum albumin (HbV/rHSA) at an Hb concentration of 8.6 g/dL. Prospective, randomized, controlled trial. Department of Surgery, School of Medicine, Keio University. Forty male Wistar rats. The rats were anesthetized with 1.5% sevoflurane inhalation throughout the experiment. Polyethylene catheters were introduced through the right jugular vein into the right atrium for infusion and into the right common carotid artery for blood withdrawal and mean arterial pressure monitoring. Shock was induced by 50% blood withdrawal. The rats showed hypotension (mean arterial pressure = 32 ± 10 mm Hg) and significant metabolic acidosis and hyperventilation. After 15 mins, they received HbV/rHSA, shed autologous blood (SAB), washed homologous red blood cells (wRBC) suspended in rHSA (wRBC/rHSA, [Hb] = 8.6 g/dL), or rHSA alone. The HbV/rHSA group restored mean arterial pressure to 93 ± 8 mm Hg at 1 hr, similar to the SAB group (92 ± 9 mm Hg), which was significantly higher compared with the rHSA (74 ± 9 mm Hg) and wRBC/rHSA (79 ± 8 mm Hg) groups. There was no remarkable difference in the blood gas variables between the resuscitated groups; however, two of eight rats in the rHSA group died before 6 hrs. After 6 hrs, the rHSA group showed significant ischemic changes in the right cerebral hemisphere relating to the ligation of the right carotid artery followed by cannulation, whereas the HbV/rHSA, SAB, and wRBC/rHSA groups showed less changes. HbV suspended in recombinant human serum albumin provides restoration from hemorrhagic shock that is comparable with that using shed autologous blood.Keywords
This publication has 34 references indexed in Scilit:
- Systemic and microvascular responses to hemorrhagic shock and resuscitation with Hb vesiclesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2002
- Hemoglobin-Vesicles as Oxygen CarriersThe American Journal of Pathology, 2001
- Molecular dimensions of Hb-based O2carriers determine constriction of resistance arteries and hypertensionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2000
- Poly(ethylene glycol)-Conjugation and Deoxygenation Enable Long-Term Preservation of Hemoglobin-Vesicles as Oxygen Carriers in a Liquid StateBioconjugate Chemistry, 2000
- Resuscitation after hemorrhage using recombinant human hemoglobin (rHb1.1) in ratsCritical Care Medicine, 1998
- Distribution of heme oxygenase isoforms in rat liver. Topographic basis for carbon monoxide-mediated microvascular relaxation.Journal of Clinical Investigation, 1998
- Surface Modification of Hemoglobin Vesicles with Poly(ethylene glycol) and Effects on Aggregation, Viscosity, and Blood Flow during 90 Exchange Transfusion in Anesthetized RatsBioconjugate Chemistry, 1997
- Physiologic responses to exchange transfusion with hemoglobin vesicles as an artificial oxygen carrier in anesthetized ratsCritical Care Medicine, 1996
- In vivo biodistribution of a radiolabeled blood substitute: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit.Proceedings of the National Academy of Sciences, 1991
- Cardiorespiratory effects of exchange transfusions with synthetic erythrocytes in ratsCritical Care Medicine, 1987